Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users
Background: Adults over the age of 65 years are more prone to gastroesophageal reflux and, as such, are commonly prescribed proton pump inhibitors (PPIs). PPIs inhibit gastric acid secretion which can have adverse effects on vitamin B12 absorption. This quasi-experimental study was conducted to dete...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Cogent Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2331205X.2017.1389639 |
_version_ | 1811227932201320448 |
---|---|
author | Judith M. Lukaszuk David A. Walker Masih Shokrani Josephine Umoren Eric J. Norman |
author_facet | Judith M. Lukaszuk David A. Walker Masih Shokrani Josephine Umoren Eric J. Norman |
author_sort | Judith M. Lukaszuk |
collection | DOAJ |
description | Background: Adults over the age of 65 years are more prone to gastroesophageal reflux and, as such, are commonly prescribed proton pump inhibitors (PPIs). PPIs inhibit gastric acid secretion which can have adverse effects on vitamin B12 absorption. This quasi-experimental study was conducted to determine whether chronic use (≥1 year) of proton pump inhibitors (PPIs) results in decreased vitamin B12 in adults aged 68–94 years, as indicated by increased urinary methylmalonic acid (uM-MA). Methods: Fifteen men and women who had been using PPIs daily for a minimum of one year were recruited. Fifteen subjects not using PPIs were age (±3 years) and gender matched to the subjects taking PPIs. Tissue stores of vitamin B12 were determined using uM-MA. Results: The majority of subjects in this study resided in assisted care living facilities (55.66%) and the remaining subjects (43.33%) were free living. There were no significant differences in uM-MA levels between those using PPIs (Mdn = 1.1 μg uM-MA/mg creatinine), and those not using PPIs (Mdn = 1.1 μg uM-MA/mg creatinine) (p = 0.75). Conclusion: Chronic use of PPIs did not alter vitamin B12 in healthy individuals aged 68–94 years. Larger studies are indicated to validate these findings. |
first_indexed | 2024-04-12T09:50:01Z |
format | Article |
id | doaj.art-b7aea659b93b4058877c428629f10f03 |
institution | Directory Open Access Journal |
issn | 2331-205X |
language | English |
last_indexed | 2024-04-12T09:50:01Z |
publishDate | 2017-01-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Cogent Medicine |
spelling | doaj.art-b7aea659b93b4058877c428629f10f032022-12-22T03:37:50ZengTaylor & Francis GroupCogent Medicine2331-205X2017-01-014110.1080/2331205X.2017.13896391389639Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor usersJudith M. Lukaszuk0David A. Walker1Masih Shokrani2Josephine Umoren3Eric J. Norman4Northern Illinois UniversityNorthern Illinois UniversityNorthern Illinois UniversityNorthern Illinois UniversityNorman Clinical Laboratory, Inc.Background: Adults over the age of 65 years are more prone to gastroesophageal reflux and, as such, are commonly prescribed proton pump inhibitors (PPIs). PPIs inhibit gastric acid secretion which can have adverse effects on vitamin B12 absorption. This quasi-experimental study was conducted to determine whether chronic use (≥1 year) of proton pump inhibitors (PPIs) results in decreased vitamin B12 in adults aged 68–94 years, as indicated by increased urinary methylmalonic acid (uM-MA). Methods: Fifteen men and women who had been using PPIs daily for a minimum of one year were recruited. Fifteen subjects not using PPIs were age (±3 years) and gender matched to the subjects taking PPIs. Tissue stores of vitamin B12 were determined using uM-MA. Results: The majority of subjects in this study resided in assisted care living facilities (55.66%) and the remaining subjects (43.33%) were free living. There were no significant differences in uM-MA levels between those using PPIs (Mdn = 1.1 μg uM-MA/mg creatinine), and those not using PPIs (Mdn = 1.1 μg uM-MA/mg creatinine) (p = 0.75). Conclusion: Chronic use of PPIs did not alter vitamin B12 in healthy individuals aged 68–94 years. Larger studies are indicated to validate these findings.http://dx.doi.org/10.1080/2331205X.2017.1389639urinary methylmalonic acidvitamin b12 deficiencyelderlyproton pump inhibitors |
spellingShingle | Judith M. Lukaszuk David A. Walker Masih Shokrani Josephine Umoren Eric J. Norman Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users Cogent Medicine urinary methylmalonic acid vitamin b12 deficiency elderly proton pump inhibitors |
title | Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users |
title_full | Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users |
title_fullStr | Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users |
title_full_unstemmed | Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users |
title_short | Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users |
title_sort | assessment of vitamin b12 tissue stores in elderly proton pump inhibitor users |
topic | urinary methylmalonic acid vitamin b12 deficiency elderly proton pump inhibitors |
url | http://dx.doi.org/10.1080/2331205X.2017.1389639 |
work_keys_str_mv | AT judithmlukaszuk assessmentofvitaminb12tissuestoresinelderlyprotonpumpinhibitorusers AT davidawalker assessmentofvitaminb12tissuestoresinelderlyprotonpumpinhibitorusers AT masihshokrani assessmentofvitaminb12tissuestoresinelderlyprotonpumpinhibitorusers AT josephineumoren assessmentofvitaminb12tissuestoresinelderlyprotonpumpinhibitorusers AT ericjnorman assessmentofvitaminb12tissuestoresinelderlyprotonpumpinhibitorusers |